Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real-world retrospective analysis

被引:7
|
作者
Zhou, Chengjing [1 ]
Jiang, Ting [1 ]
Li, Rongzhen [1 ]
Yuan, Yan [1 ]
Xie, Weihao [1 ]
Huang, Xiaoxue [1 ]
Wang, Qiaoxuan [1 ]
Chang, Hui [1 ]
Chen, Gong [2 ]
Li, Yuhong [3 ]
Zeng, Zhifan [1 ]
Xiao, Weiwei [1 ]
Gao, Yuanhong [1 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol, State Key Lab Oncol South China,Canc Ctr, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Colorectal Surg, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
MISMATCH; NIVOLUMAB; TUMORS;
D O I
10.1002/cac2.12199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:921 / 924
页数:4
相关论文
共 50 条
  • [1] Cardiotoxicity Related to Immune Checkpoint Inhibitors: A Real-World Retrospective Analysis
    She, Jianqing
    Liu, Hui
    Wu, Haoyu
    Tuerhongjiang, Gulinigaer
    Zheng, Tao
    Bai, Ling
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [2] Autoimmune Hematological Toxicities of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Database Analysis
    Keerty, Dinesh
    Haddad, Philip A.
    Ramadas, Poornima
    Master, Samip R.
    [J]. BLOOD, 2022, 140 : 13160 - 13161
  • [3] Hyperprogression on immune checkpoint inhibitors: A single institution, real-world retrospective analysis.
    Paydary, Koosha
    Moturi, Krishna Rekha
    Baral, Binav
    Farooq, Muhammad Zain
    Lad, Thomas E.
    Mangla, Ankit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real-world analysis
    Kadono, Toru
    Iwasa, Satoru
    Hirose, Toshiharu
    Hirano, Hidekazu
    Okita, Natsuko
    Shoji, Hirokazu
    Takashima, Atsuo
    Kato, Ken
    [J]. CANCER MEDICINE, 2024, 13 (12):
  • [5] Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data
    Lippenszky, Levente
    Mittendorf, Kathleen F.
    Kiss, Zoltan
    LeNoue-Newton, Michele L.
    Napan-Molina, Pablo
    Rahman, Protiva
    Ye, Cheng
    Laczi, Balazs
    Csernai, Eszter
    Jain, Neha M.
    Holt, Marilyn E.
    Maxwell, Christina N.
    Ball, Madeleine
    Ma, Yufang
    Mitchell, Margaret B.
    Johnson, Douglas B.
    Smith, David S.
    Park, Ben H.
    Micheel, Christine M.
    Fabbri, Daniel
    Wolber, Jan
    Osterman, Travis J.
    [J]. JCO CLINICAL CANCER INFORMATICS, 2024, 8
  • [6] Hematologic and lymphatic system toxicities associated with immune checkpoint inhibitors: a real-world study
    Li, Na
    Feng, Yong
    Chen, Xiaoling
    Li, Ye
    Zhang, Chengmiao
    Yin, Yin
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar
    Benkhadra, Maria
    Elazzazy, Shereen
    Hamad, Anas Ahmad
    Elkhatim, Mohamed S.
    Gulied, Amaal
    Sahal, Arwa Osama
    Alasmar, Aya
    Jibril, Farah I.
    Afifi, Hebatalla Mahmoud
    Nasser, Sahar
    Alnajjar, Afnan
    Dawoud, Rawan
    Omar, Nabil E.
    [J]. BLOOD, 2023, 142
  • [8] Real-world cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: a retrospective controlled cohort study
    Zhang, Chuan
    Chen, Zhulu
    Mo, Chunhua
    Gao, Diansha
    Zhu, Yuxi
    Qin, Shu
    Zuo, Zhong
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 6074 - +
  • [9] Real-world data in the era of immune checkpoint inhibitors
    Narita, Yukiya
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S250 - S250